Myeloma Center

The Myeloma Center at New York Presbyterian – Weill Cornell Medical Center is a comprehensive program for the treatment of multiple myeloma and related plasma cell diseases. Our focus is on providing cutting edge medical technologies and the latest in myeloma treatment personalized to each patient.

News

March 11, 2019
Amyloidosis is a rare disease characterized by a buildup of abnormal proteins called amyloids within organs like the heart, kidneys and liver. The Myeloma Center’s Dr. Cara...
February 4, 2019
Cells
Three-drug combinations have demonstrated benefit both for newly diagnosed myeloma patients who go on to undergo autologous stem cell transplantation, as well as for those who are...
January 22, 2019
Renal impairment, a common comorbidity of multiple myeloma, occurs when the body’s kidneys cannot efficiently filter waste products from the blood. Associated with poor survival...

In May 2018, the Myeloma Center moved to 425 E. 61st St – 8th Floor. Learn more about this location.

For Patients

Make an appointment, prepare for your first visit, and access our health information library, complete with resources on frequently asked questions, our ongoing support groups and the latest research and treatments.

Find out more about patient care

Research and Clinical Trials

Research and clinical trials are critical to developing new treatments and cures for myeloma, amyloidosis and related plasma cell disorders. Learn about our world-class research program which offers Myeloma Center patients access to the newest therapies.

Find out more about research

Our Team

Meet our healthcare team and learn about our approach to care. We have many years of expertise in providing outstanding clinical care in the treatment of multiple myeloma, amyloidosis and other plasma cell disorders.

View All Team Members